Financial Summary (All financials)
| In millions, except per share items | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 | Dec-31-08 | Dec-31-07 |
| Revenues | 2,007.7 | 1,935.0 | 1,708.1 | 1,415.9 | 1,223.4 | 2,429.3 | 3,128.2 | 3,503.8 |
| Revenue growth | 3.8% | 13.3% | 20.6% | 15.7% | -49.6% | -22.3% | -10.7% | 5.2% |
| Cost of goods sold | 1,403.8 | 1,283.1 | 1,202.9 | 1,028.0 | 861.6 | 1,975.3 | 2,414.6 | 3,014.2 |
| Gross profit | 603.9 | 651.9 | 505.2 | 387.9 | 361.8 | 454.0 | 713.6 | 489.6 |
| Gross margin | 30.1% | 33.7% | 29.6% | 27.4% | 29.6% | 18.7% | 22.8% | 14.0% |
| Sales and marketing | 158.9 | 146.6 | 153.3 | 132.6 | 113.4 | 197.0 | 228.1 | |
| Research and development | 56.8 | 49.0 | 54.0 | 47.5 | 38.1 | 75.0 | 81.5 | |
| General and administrative | 140.1 | 126.5 | 140.0 | 100.1 | 93.6 | 124.2 | 111.8 | 113.2 |
| EBITA | 253.1 | 334.4 | 162.3 | 116.5 | 122.5 | 59.3 | 299.7 | 382.4 |
| EBITA margin | 12.6% | 17.3% | 9.5% | 8.2% | 10.0% | 2.4% | 9.6% | 10.9% |
| Amortization of intangibles | 17.9 | 19.2 | 14.1 | 8.7 | 9.0 | 44.7 | 45.6 | 44.7 |
| EBIT | 235.2 | 315.2 | 148.2 | 107.8 | 113.5 | 14.6 | 254.1 | 337.7 |
| EBIT margin | 11.7% | 16.3% | 8.7% | 7.6% | 9.3% | 0.6% | 8.1% | 9.6% |
| Pre-tax income | 190.2 | 244.0 | 103.2 | 67.8 | 73.6 | -19.5 | -161.7 | 284.0 |
| Income taxes | 46.1 | 72.3 | 27.5 | 10.3 | 6.6 | -8.9 | 43.6 | 76.7 |
| Tax rate | 24.2% | 29.6% | 26.6% | 15.2% | 9.0% | 45.6% | | 27.0% |
| Earnings from continuing ops | 144.1 | 201.5 | 77.8 | 60.6 | 69.8 | -19.6 | -203.5 | 207.3 |
| Earnings from discontinued ops | 9.7 | -27.2 | 101.3 | 131.5 | 108.1 | 9.7 | 8.3 | |
| Net income | 153.8 | 174.3 | 179.1 | 192.1 | 177.9 | -9.9 | -195.2 | 207.3 |
| Net margin | 7.7% | 9.0% | 10.5% | 13.6% | 14.5% | -0.4% | -6.2% | 5.9% |
| |
| Diluted EPS | $1.96 | $2.51 | $0.83 | $1.24 | $1.40 | ($0.41) | ($4.34) | |
| Shares outstanding (diluted) | 73.4 | 80.4 | 93.6 | 49.0 | 49.9 | 48.3 | 46.9 | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|